A synthetic cyclic heptapeptide melanocortin receptor agonist studied in laboratory research on MC4R and central melanocortin pathway signaling in experimental models. Supplied lyophilized for laboratory research use only — not for human consumption, veterinary use, clinical application, or therapeutic treatment.
PT-141
$39.00
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist and a metabolite of Melanotan II, studied in laboratory research on melanocortin receptor signaling. It is used in structured in vitro and model-based studies designed to yield reproducible observations under standardized conditions.
- Synthetic cyclic heptapeptide supplied for laboratory research use only.
- Referenced in published research examining non-selective agonism across melanocortin receptor subtypes, with particular attention to MC4R, in experimental models.
- Studied in research on central melanocortin pathway signaling, distinguishing it from peripheral vascular mechanisms studied in other compound classes.
- Suitable for controlled, repeatable studies investigating melanocortin receptor pathway mechanisms.
Research Disclaimer: Second Wind Research products are sold exclusively for laboratory and scientific research. They are not intended for human consumption, veterinary use, clinical application, or therapeutic treatment. All research must be conducted by qualified professionals in appropriate laboratory environments.
| Size | 10 mg |
|---|
Related products
Updating…